GCG, glucagon, 2641

N. diseases: 441; N. variants: 10
Disease: Substance Use Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders 		0.010 Biomarker group BEFREE Seventeen studies were included, investigating the effect of the GLP-1-receptor agonists exendin-4, fluoro-exendin-4, liraglutide, AC3174 and GLP-1 (7-36) on SUD-related behavioural effects of ethanol, cocaine, amphetamine, and/or nicotine.All studies used rodents as subjects. 30946836 2019